{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:09:47Z","timestamp":1778206187292,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cjca.2026.03.038","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:14:33Z","timestamp":1774599273000},"page":"902-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene-based Therapies for Cardiovascular Medicine\u2014Incorporating Molecular Medicine into Contemporary Cardiology"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-9028","authenticated-orcid":false,"given":"Gavin Y.","family":"Oudit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia G.","family":"Priori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.03.038_bib1","first-page":"2312","article-title":"Canadian Cardiovascular Society clinical practice update on cardiogenetic testing","volume":"41","author":"Care","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.03.038_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.03.038_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/hum.2015.025","article-title":"Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective","volume":"26","author":"Hastie","year":"2015","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2026.03.038_bib5","first-page":"914","article-title":"New approaches to cardiac gene therapy delivery","volume":"42","author":"Veera","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib6","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41591-025-04011-z","article-title":"Cardiotropic AAV gene therapy for heart failure: a phase 1 trial","volume":"31","author":"Henry","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2026.03.038_bib7","first-page":"902","article-title":"The past, present, and future of cardiac gene therapy","volume":"42","author":"Hajjar","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib8","first-page":"1015","article-title":"Gene-based therapies for genetic cardiomyopathies: molecular medicine for heart disease","volume":"42","author":"Sharma","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib9","first-page":"930","article-title":"Gene replacement therapy in patients with cardiac disease: challenges in trial design and management of adverse events","volume":"42","author":"Maurizi","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib10","first-page":"964","article-title":"RNA-based therapies for treating monogenic cardiomyopathies","volume":"42","author":"Edwards","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib11","first-page":"979","article-title":"Emerging gene therapies for inherited arrhythmia syndromes","volume":"42","author":"Grisorio","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib12","first-page":"1001","article-title":"Nucleic acid based therapies \u2014 the next frontier in treating dyslipidemias","volume":"42","author":"Hegele","year":"2026"},{"key":"10.1016\/j.cjca.2026.03.038_bib13","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/HYPERTENSIONAHA.122.19430","article-title":"Novel pharmacological approaches in the treatment of hypertension: a focus on RNA-based therapeutics","volume":"80","author":"Addison","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2026.03.038_bib14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(25)02064-1","article-title":"New drug therapies for hypertension","volume":"407","author":"Azizi","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.03.038_bib15","first-page":"1439","article-title":"Zilebesiran for hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"Reply. N Engl J Med"},{"key":"10.1016\/j.cjca.2026.03.038_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacbts.2021.04.004","article-title":"Antisense inhibition of angiotensinogen with IONIS-AGT-L(Rx): results of phase 1 and phase 2 studies","volume":"6","author":"Morgan","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2026.03.038_bib17","first-page":"1037","article-title":"A primer on cardiovascular gene therapy for the practitioner: what clinicians need to know","volume":"42","author":"Argueta Portillo","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib18","first-page":"1041","article-title":"Contemporary controversies around medical ethics of gene therapy for cardiovascular disease","volume":"42","author":"Greco","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib19","first-page":"946","article-title":"Outcome monitoring and intermediate end points for gene therapy","volume":"42","author":"Kukavica","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.03.038_bib20","first-page":"1044","article-title":"Economic issues and viability of gene-based molecular therapies for cardiovascular disease","volume":"42","author":"Hl\u00e1vka","year":"2026","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26002874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26002874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:14:03Z","timestamp":1778202843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26002874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0828282X26002874"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.03.038","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-based Therapies for Cardiovascular Medicine\u2014Incorporating Molecular Medicine into Contemporary Cardiology","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}